William D. Hwang
Research Subjects
William D. Hwang has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Mahmud Mossa-Basha
Department of Radiology, University of Washington, Seattle, USA
3 shared publications Yoshimi Anzai
2 shared publications- Adam de Havenon
Department of Neurology, Yale School of Medicine, New Haven, CT (A.d.H.).
1 shared publication Alejandro Calniquer
Department of Orthopaedics and Sports Medicine, University of Washington, Seattle, United States
1 shared publication- Andrew L. Avins
Kaiser Permanente Northern California
1 shared publication - C. M. Smith
From the Department of Radiology, University of Washington, Seattle, Washington
1 shared publication
Latest Publications
- Open Access
- 2 May 2019
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 40 (5) , 908-915
Lumbar Spinal Stenosis Severity by CT or MRI Does Not Predict Response to Epidural Corticosteroid versus Lidocaine Injections
BACKGROUND AND PURPOSE: Epidural steroid injections may offer little-to-no short-term benefit in the overall population of patients with symptomatic spinal stenosis compared with lidocaine alone. We investigated whether imaging could identify subgroups of patients who might benefit most. MATERIALS AND METHODS: A secondary analysis of the Lumbar Epidural Steroid Injections for Spinal Stenosis prospective, double-blind trial was performed, and patients were randomized to receive an epidural injection of lidocaine with or without corticosteroids. Patients (n = 350) were evaluated for qualitative and quantitative MR imaging or CT measures of lumbar spinal stenosis. The primary clinical end points were the Roland-Morris Disability Questionnaire and the leg pain numeric rating scale at 3 weeks following injection. ANCOVA was used to assess the significance of interaction terms between imaging measures of spinal stenosis and injectate type on clinical improvement. RESULTS: There was no difference in the improvement of disability or leg pain scores at 3 weeks between patients injected with epidural lidocaine alone compared with corticosteroid and lidocaine when accounting for the primary imaging measures of qualitative spinal stenosis assessment (interaction coefficients for disability score, −0.1; 95% CI, −1.3 to 1.2; P = .90; and for the leg pain score, 0.1; 95% CI, −0.6 to 0.8; P = .81) or the quantitative minimum thecal sac cross-sectional area (interaction coefficients for disability score, 0.01; 95% CI, −0.01 to 0.03; P = .40; and for the leg pain score, 0.01; 95% CI, −0.01 to 0.03; P = .33). CONCLUSIONS: Imaging measures of spinal stenosis are not associated with differential clinical responses following epidural corticosteroid injection.
- 2 May 2019
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 40 (5) , 908-915
Open AccessLumbar Spinal Stenosis Severity by CT or MRI Does Not Predict Response to Epidural Corticosteroid versus Lidocaine Injections
BACKGROUND AND PURPOSE: Epidural steroid injections may offer little-to-no short-term benefit in the overall population of patients with symptomatic spinal stenosis compared with lidocaine alone. We investigated whether imaging could identify subgroups of patients who might benefit most. MATERIALS AND METHODS: A secondary analysis of the Lumbar Epidural Steroid Injections for Spinal Stenosis prospective, double-blind trial was performed, and patients were randomized to receive an epidural injection of lidocaine with or without corticosteroids. Patients (n = 350) were evaluated for qualitative and quantitative MR imaging or CT measures of lumbar spinal stenosis. The primary clinical end points were the Roland-Morris Disability Questionnaire and the leg pain numeric rating scale at 3 weeks following injection. ANCOVA was used to assess the significance of interaction terms between imaging measures of spinal stenosis and injectate type on clinical improvement. RESULTS: There was no difference in the improvement of disability or leg pain scores at 3 weeks between patients injected with epidural lidocaine alone compared with corticosteroid and lidocaine when accounting for the primary imaging measures of qualitative spinal stenosis assessment (interaction coefficients for disability score, −0.1; 95% CI, −1.3 to 1.2; P = .90; and for the leg pain score, 0.1; 95% CI, −0.6 to 0.8; P = .81) or the quantitative minimum thecal sac cross-sectional area (interaction coefficients for disability score, 0.01; 95% CI, −0.01 to 0.03; P = .40; and for the leg pain score, 0.01; 95% CI, −0.01 to 0.03; P = .33). CONCLUSIONS: Imaging measures of spinal stenosis are not associated with differential clinical responses following epidural corticosteroid injection.
- Open Access
- 7 April 2016
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 37 (8) , 1561-1566
Evaluation of Focal Cervical Spinal Cord Lesions in Multiple Sclerosis: Comparison of White Matter-Suppressed T1 Inversion Recovery Sequence versus Conventional STIR and Proton Density-Weighted Turbo Spin-Echo Sequences
BACKGROUND AND PURPOSE: Conventional MR imaging of the cervical spinal cord in MS is challenged by numerous artifacts and interreader variability in lesion counts. This study compares the relatively novel WM-suppressed T1 inversion recovery sequence with STIR and proton density–weighted TSE sequences in the evaluation of cervical cord lesions in patients with MS. MATERIALS AND METHODS: Retrospective blinded analysis of cervical cord MR imaging examinations of 50 patients with MS was performed by 2 neuroradiologists. In each patient, the number of focal lesions and overall lesion conspicuity were measured in the STIR/proton density–weighted TSE and WM-suppressed T1 inversion recovery sequence groups. Independent side-by-side comparison was performed to categorize the discrepant lesions as either “definite” or “spurious.” Lesion contrast ratio and edge sharpness were independently calculated in each sequence. RESULTS: Substantial interreader agreement was noted on the WM-suppressed T1 inversion recovery sequence (κ = 0.82) compared with STIR/proton density–weighted TSE (κ = 0.52). Average lesion conspicuity was better on the WM-suppressed T1 inversion recovery sequence (conspicuity of 3.1/5.0 versus 3.7/5.0, P < .01, in the WM-suppressed T1 inversion recovery sequence versus STIR/proton density–weighted TSE, respectively). Spurious lesions were more common on STIR/proton density–weighted TSE than on the WM-suppressed T1 inversion recovery sequence (23 and 30 versus 3 and 4 by readers 1 and 2, respectively; P < .01). More “definite” lesions were missed on STIR/proton density–weighted TSE compared with the WM-suppressed T1 inversion recovery sequence (37 and 38 versus 3 and 6 by readers 1 and 2, respectively). Lesion contrast ratio and edge sharpness were highest on the WM-suppressed T1 inversion recovery sequence. CONCLUSIONS: There is better interreader consistency in the lesion count on the WM-suppressed T1 inversion recovery sequence compared with STIR/proton density–weighted TSE sequences. The focal cord lesions are visualized with better conspicuity due to better contrast ratio and edge sharpness. There are fewer spurious lesions on the WM-suppressed T1 inversion recovery sequence compared with STIR/proton density–weighted TSE. The WM-suppressed T1 inversion recovery sequence could potentially be substituted for either STIR or proton density–weighted TSE sequences in routine clinical protocols.
- 7 April 2016
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 37 (8) , 1561-1566
Open AccessEvaluation of Focal Cervical Spinal Cord Lesions in Multiple Sclerosis: Comparison of White Matter-Suppressed T1 Inversion Recovery Sequence versus Conventional STIR and Proton Density-Weighted Turbo Spin-Echo Sequences
BACKGROUND AND PURPOSE: Conventional MR imaging of the cervical spinal cord in MS is challenged by numerous artifacts and interreader variability in lesion counts. This study compares the relatively novel WM-suppressed T1 inversion recovery sequence with STIR and proton density–weighted TSE sequences in the evaluation of cervical cord lesions in patients with MS. MATERIALS AND METHODS: Retrospective blinded analysis of cervical cord MR imaging examinations of 50 patients with MS was performed by 2 neuroradiologists. In each patient, the number of focal lesions and overall lesion conspicuity were measured in the STIR/proton density–weighted TSE and WM-suppressed T1 inversion recovery sequence groups. Independent side-by-side comparison was performed to categorize the discrepant lesions as either “definite” or “spurious.” Lesion contrast ratio and edge sharpness were independently calculated in each sequence. RESULTS: Substantial interreader agreement was noted on the WM-suppressed T1 inversion recovery sequence (κ = 0.82) compared with STIR/proton density–weighted TSE (κ = 0.52). Average lesion conspicuity was better on the WM-suppressed T1 inversion recovery sequence (conspicuity of 3.1/5.0 versus 3.7/5.0, P < .01, in the WM-suppressed T1 inversion recovery sequence versus STIR/proton density–weighted TSE, respectively). Spurious lesions were more common on STIR/proton density–weighted TSE than on the WM-suppressed T1 inversion recovery sequence (23 and 30 versus 3 and 4 by readers 1 and 2, respectively; P < .01). More “definite” lesions were missed on STIR/proton density–weighted TSE compared with the WM-suppressed T1 inversion recovery sequence (37 and 38 versus 3 and 6 by readers 1 and 2, respectively). Lesion contrast ratio and edge sharpness were highest on the WM-suppressed T1 inversion recovery sequence. CONCLUSIONS: There is better interreader consistency in the lesion count on the WM-suppressed T1 inversion recovery sequence compared with STIR/proton density–weighted TSE sequences. The focal cord lesions are visualized with better conspicuity due to better contrast ratio and edge sharpness. There are fewer spurious lesions on the WM-suppressed T1 inversion recovery sequence compared with STIR/proton density–weighted TSE. The WM-suppressed T1 inversion recovery sequence could potentially be substituted for either STIR or proton density–weighted TSE sequences in routine clinical protocols.
- 1 January 2016
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 40 (2) , 320-325
Qualitative Comparison of Noncontrast Head Dual-Energy Computed Tomography Using Rapid Voltage Switching Technique and Conventional Computed Tomography
Dual-energy computed tomography (DECT) allows image reconstruction along a spectrum of virtual monochromatic energy levels. We sought to determine the optimal energy level(s) for viewing supratentorial brain and posterior fossa and compare those to polychromatic conventional CT (CCT). Furthermore, we compared 2 groups scanned with separate DECT imaging protocols. In addition, we quantify the radiation dose of DECT versus CCT. Forty-four nonacute patients underwent noncontrast DECT and recent CCT on the same scanner. Dual-energy CT images of the head were reconstructed at 5 keV intervals from 50 to 100 keV and randomized with CCT for blinded reader analysis. Evaluation of gray-white matter differentiation, posterior fossa artifact, and overall image noise was performed in consensus using a 5-point scale. In addition, the CTDIvol was compared with CCT examinations. Optimal monochromatic viewing levels in evaluating gray-white matter differentiation were 50 to 55 keV and 50 to 60 keV, using regular-dose DECT (R-DECT) and low-dose DECT (L-DECT), respectively. The optimal levels for mitigating posterior fossa artifacts were 80 to 100 keV utilizing both R-DECT and L-DECT, whereas the optimal viewing levels for improved overall image noise were 60 to 65 keV and 65 to 70 keV for R-DECT and L-DECT, respectively. Readers favored both DECT techniques over CCT. The CTDIvol for DECT was 10% and 37% lower than CCT without a statistically significant reduction in image quality. Optimized noncontrast DECT compared favorably to CCT, with a significant dose reduction benefit.
- 1 January 2016
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 40 (2) , 320-325
Qualitative Comparison of Noncontrast Head Dual-Energy Computed Tomography Using Rapid Voltage Switching Technique and Conventional Computed Tomography
Dual-energy computed tomography (DECT) allows image reconstruction along a spectrum of virtual monochromatic energy levels. We sought to determine the optimal energy level(s) for viewing supratentorial brain and posterior fossa and compare those to polychromatic conventional CT (CCT). Furthermore, we compared 2 groups scanned with separate DECT imaging protocols. In addition, we quantify the radiation dose of DECT versus CCT. Forty-four nonacute patients underwent noncontrast DECT and recent CCT on the same scanner. Dual-energy CT images of the head were reconstructed at 5 keV intervals from 50 to 100 keV and randomized with CCT for blinded reader analysis. Evaluation of gray-white matter differentiation, posterior fossa artifact, and overall image noise was performed in consensus using a 5-point scale. In addition, the CTDIvol was compared with CCT examinations. Optimal monochromatic viewing levels in evaluating gray-white matter differentiation were 50 to 55 keV and 50 to 60 keV, using regular-dose DECT (R-DECT) and low-dose DECT (L-DECT), respectively. The optimal levels for mitigating posterior fossa artifacts were 80 to 100 keV utilizing both R-DECT and L-DECT, whereas the optimal viewing levels for improved overall image noise were 60 to 65 keV and 65 to 70 keV for R-DECT and L-DECT, respectively. Readers favored both DECT techniques over CCT. The CTDIvol for DECT was 10% and 37% lower than CCT without a statistically significant reduction in image quality. Optimized noncontrast DECT compared favorably to CCT, with a significant dose reduction benefit.
- Open Access
- 1 June 2015
- Published by Wolters Kluwer Health in Stroke
- Vol. 46 (6) , 1567-1573
Multicontrast High-Resolution Vessel Wall Magnetic Resonance Imaging and Its Value in Differentiating Intracranial Vasculopathic Processes
Background and Purpose—: Although studies have attempted to differentiate intracranial vascular disease using vessel wall magnetic resonance imaging (VWI), none have incorporated multicontrast imaging. This study uses T1- and T2-weighted VWI to differentiate intracranial vasculopathies. Methods—: We retrospectively reviewed patients with clinically defined intracranial vasculopathies causing luminal stenosis/irregularity who underwent VWI studies. Two blinded experts evaluated T1 precontrast and postcontrast and T2-weighted VWI characteristics, including the pattern of wall thickening; presence, pattern, and intensity of postcontrast enhancement; and T2 signal characteristics. Results—: Twenty-one cases of atherosclerosis (intracranial atherosclerotic disease [ICAD]), 4 of reversible cerebral vasoconstriction syndrome, and 4 of vasculitis were identified, with a total of 118 stenotic lesions (81 ICAD, 22 reversible cerebral vasoconstriction syndrome, and 15 vasculitic lesions). There was substantial to excellent inter-reader agreement for the assessment of lesional T2 hyperintensity ( κ =0.80), pattern of wall thickening ( κ =0.87), presence ( κ =0.90), pattern ( κ =0.73), and intensity ( κ =0.77) of enhancement. ICAD lesions were significantly more likely to have eccentric wall involvement (90.1%) than reversible cerebral vasoconstriction syndrome (8.2%; P P P <0.001). There were also significant differences in the presence, intensity, and pattern of enhancement between all lesion types. Combining T1 and T2 VWI increased the sensitivity of VWI in differentiating ICAD from other vasculopathies from 90.1% to 96.3%. Conclusions—: Multicontrast VWI can be a complementary tool for intracranial vasculopathy differentiation, which often leads to more invasive workups when reversible cerebral vasoconstriction syndrome and vasculitis are in the differential diagnosis.
- 1 June 2015
- Published by Wolters Kluwer Health in Stroke
- Vol. 46 (6) , 1567-1573
Open AccessMulticontrast High-Resolution Vessel Wall Magnetic Resonance Imaging and Its Value in Differentiating Intracranial Vasculopathic Processes
Background and Purpose—: Although studies have attempted to differentiate intracranial vascular disease using vessel wall magnetic resonance imaging (VWI), none have incorporated multicontrast imaging. This study uses T1- and T2-weighted VWI to differentiate intracranial vasculopathies. Methods—: We retrospectively reviewed patients with clinically defined intracranial vasculopathies causing luminal stenosis/irregularity who underwent VWI studies. Two blinded experts evaluated T1 precontrast and postcontrast and T2-weighted VWI characteristics, including the pattern of wall thickening; presence, pattern, and intensity of postcontrast enhancement; and T2 signal characteristics. Results—: Twenty-one cases of atherosclerosis (intracranial atherosclerotic disease [ICAD]), 4 of reversible cerebral vasoconstriction syndrome, and 4 of vasculitis were identified, with a total of 118 stenotic lesions (81 ICAD, 22 reversible cerebral vasoconstriction syndrome, and 15 vasculitic lesions). There was substantial to excellent inter-reader agreement for the assessment of lesional T2 hyperintensity ( κ =0.80), pattern of wall thickening ( κ =0.87), presence ( κ =0.90), pattern ( κ =0.73), and intensity ( κ =0.77) of enhancement. ICAD lesions were significantly more likely to have eccentric wall involvement (90.1%) than reversible cerebral vasoconstriction syndrome (8.2%; P P P <0.001). There were also significant differences in the presence, intensity, and pattern of enhancement between all lesion types. Combining T1 and T2 VWI increased the sensitivity of VWI in differentiating ICAD from other vasculopathies from 90.1% to 96.3%. Conclusions—: Multicontrast VWI can be a complementary tool for intracranial vasculopathy differentiation, which often leads to more invasive workups when reversible cerebral vasoconstriction syndrome and vasculitis are in the differential diagnosis.
- Open Access
- 28 March 2014
- Published by Georg Thieme Verlag KG in Evidence-Based Spine-Care Journal
- Vol. 05 (01) , 052-056
A Case of Tophaceous Gout in the Lumbar Spine: A Review of the Literature and Treatment Recommendations
Study Design Case report. Objective The objective of this study is to report the occurrence of tophaceous gout in the lumbar spine. Methods Using a case report to illustrate the key points of gout in the spine, we provide a brief review of gout in the literature as it relates to its orthopedic and spinal manifestations as well as guidelines for management. Results This case report details the occurrence of a large and clinically significant finding of tophaceous gout in the lumbar spine in a 24-year-old man with a known history of gout and a 3-year history of progressive back pain. Conclusion A high index of suspicion can assist in diagnosis of patients presenting with back pain or neurologic findings with a history of gout. A previous history of gout (especially the presence of tophi), hyperuricemia, and the radiological characteristics presented here should aid the clinician in making the diagnosis of spinal gout. Early diagnosis has the potential to prevent the need for surgical intervention.
- 28 March 2014
- Published by Georg Thieme Verlag KG in Evidence-Based Spine-Care Journal
- Vol. 05 (01) , 052-056
Open AccessA Case of Tophaceous Gout in the Lumbar Spine: A Review of the Literature and Treatment Recommendations
Study Design Case report. Objective The objective of this study is to report the occurrence of tophaceous gout in the lumbar spine. Methods Using a case report to illustrate the key points of gout in the spine, we provide a brief review of gout in the literature as it relates to its orthopedic and spinal manifestations as well as guidelines for management. Results This case report details the occurrence of a large and clinically significant finding of tophaceous gout in the lumbar spine in a 24-year-old man with a known history of gout and a 3-year history of progressive back pain. Conclusion A high index of suspicion can assist in diagnosis of patients presenting with back pain or neurologic findings with a history of gout. A previous history of gout (especially the presence of tophi), hyperuricemia, and the radiological characteristics presented here should aid the clinician in making the diagnosis of spinal gout. Early diagnosis has the potential to prevent the need for surgical intervention.